Header Logo

Connection

Michael Megaly to Humans

Back to Details
This is a "connection" page, showing publications Michael Megaly has written about Humans.
Michael Megaly
Connection Strength
3.275
Humans
  1. Impact of aortic root abscess on outcomes in infective endocarditis and predictors of in-hospital mortality: A meta-analysis. Heart Lung. 2026 Jan-Feb; 75:337-346.
    View in: PubMed
    Score: 0.054
  2. Cardiogenic Shock in Takotsubo vs Acute Myocardial Infarction: Insights From the National Readmission Database 2016-2022. Can J Cardiol. 2025 Dec; 41(12):2431-2439.
    View in: PubMed
    Score: 0.054
  3. Characteristics and Outcomes of ST-Segment Elevation Myocardial Infarction Due to Left Main Coronary Artery Stenosis. Am J Cardiol. 2026 Jan 15; 259:38-44.
    View in: PubMed
    Score: 0.054
  4. Early vs. delayed mechanical circulatory support in patients with acute myocardial infarction and cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2024 May 28; 13(5):390-397.
    View in: PubMed
    Score: 0.049
  5. Retrograde stent target technique for left main chronic total Occlusion revascularization. J Invasive Cardiol. 2023 Dec; 35(12).
    View in: PubMed
    Score: 0.047
  6. Use of a Multidisciplinary Shock Team and Inhospital Mortality in Patients With Cardiogenic Shock. Am J Cardiol. 2023 11 01; 206:200-201.
    View in: PubMed
    Score: 0.046
  7. The summer effect on STEMI outcomes: Insights from teaching hospitals. Cardiovasc Revasc Med. 2024 Jan; 58:101-103.
    View in: PubMed
    Score: 0.046
  8. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention of the Left Anterior Descending Artery. Am J Cardiol. 2023 04 15; 193:75-82.
    View in: PubMed
    Score: 0.045
  9. Utilization of TandemHeart in cardiogenic shock: Insights from the THEME registry. Catheter Cardiovasc Interv. 2023 03; 101(4):756-763.
    View in: PubMed
    Score: 0.045
  10. Meta-Analysis on Invasive Versus Conservative Strategy in Patients Older Than Seventy Years With Non-ST Elevation Myocardial Infarction. Am J Cardiol. 2023 01 01; 186:66-70.
    View in: PubMed
    Score: 0.044
  11. Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol. 2023 01 01; 186:209-215.
    View in: PubMed
    Score: 0.044
  12. Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 11; 100(6):1021-1029.
    View in: PubMed
    Score: 0.044
  13. Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied. Eur Heart J Qual Care Clin Outcomes. 2022 Sep 05; 8(6):600-601.
    View in: PubMed
    Score: 0.043
  14. Comparative Analysis of Patient Characteristics in Chronic Total Occlusion Revascularization Studies: Trials vs Real-World Registries. JACC Cardiovasc Interv. 2022 07 25; 15(14):1441-1449.
    View in: PubMed
    Score: 0.043
  15. Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery. Am J Cardiol. 2022 09 15; 179:11-17.
    View in: PubMed
    Score: 0.043
  16. The MANTA Vascular Closure Device: Requiring Attention From Beginning to End, Reply. Cardiovasc Revasc Med. 2022 07; 40:207.
    View in: PubMed
    Score: 0.042
  17. Extra-Stent Subintimal Plaque Modification: A Novel Technique to Overcome Resistant Stent Underexpansion. Cardiovasc Revasc Med. 2022 07; 40S:276-278.
    View in: PubMed
    Score: 0.042
  18. Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries. JACC Cardiovasc Interv. 2022 02 14; 15(3):297-304.
    View in: PubMed
    Score: 0.042
  19. Side Power Knuckle and Antegrade-Antegrade Dissection Re-Entry: Techniques to Overcome Difficulties in Chronic Occlusion?Revascularization. JACC Cardiovasc Interv. 2022 01 10; 15(1):e13-e15.
    View in: PubMed
    Score: 0.041
  20. Wire Entrapment and Unraveling in the Aorta: Snaring Technique for the Nonvisible Filament. JACC Cardiovasc Interv. 2022 01 24; 15(2):e21-e22.
    View in: PubMed
    Score: 0.041
  21. Incidence and Long-Term Outcomes of Stroke in Patients Presenting With ST-Segment Elevation-Myocardial Infarction: Insights From the Midwest STEMI Consortium. J Am Heart Assoc. 2021 12 07; 10(23):e022489.
    View in: PubMed
    Score: 0.041
  22. "Power Carlino": A Novel Method for Modifying Wire-Impenetrable Proximal Caps During Chronic Total Occlusion Revascularization. JACC Cardiovasc Interv. 2021 11 22; 14(22):2521-2522.
    View in: PubMed
    Score: 0.041
  23. Outcomes of successful vs. failed contemporary chronic total occlusion percutaneous coronary intervention. Cardiovasc Interv Ther. 2022 Jul; 37(3):483-489.
    View in: PubMed
    Score: 0.041
  24. Complications and failure modes of coronary microcatheters. EuroIntervention. 2021 Aug 06; 17(5):e436-e438.
    View in: PubMed
    Score: 0.040
  25. Diabetic Patients Who Present With ST-Elevation Myocardial Infarction. Cardiovasc Revasc Med. 2022 05; 38:89-93.
    View in: PubMed
    Score: 0.040
  26. Trends and Outcomes of Uilization of Thrombectomy During Primary Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2022 03; 36:83-88.
    View in: PubMed
    Score: 0.040
  27. Complications and Failure Modes of Polymer-Jacketed Guidewires; Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 03; 36:132-135.
    View in: PubMed
    Score: 0.039
  28. Complications and failure modes of coronary embolic protection devices: Insights from the MAUDE database. Catheter Cardiovasc Interv. 2022 02; 99(2):405-410.
    View in: PubMed
    Score: 0.039
  29. Complications and Failure Modes of Covered Coronary Stents: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 02; 35:157-160.
    View in: PubMed
    Score: 0.039
  30. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease. Cardiovasc Revasc Med. 2022 02; 35:76-82.
    View in: PubMed
    Score: 0.039
  31. Complications and Failure Modes of Stingray LP Balloon: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 02; 35:187-188.
    View in: PubMed
    Score: 0.039
  32. Complications of the MANTA Closure Device: Insights From MAUDE Database. Cardiovasc Revasc Med. 2022 01; 34:75-79.
    View in: PubMed
    Score: 0.039
  33. Outcomes of Percutaneous and Surgical Pulmonary Valve Implantation. Cardiovasc Revasc Med. 2021 11; 32:27-32.
    View in: PubMed
    Score: 0.039
  34. Reply: TAVR With or Without Embolic Cerebral Protection. JACC Cardiovasc Interv. 2020 12 14; 13(23):2817.
    View in: PubMed
    Score: 0.038
  35. Impact of Chronic Total Occlusion Revascularization on Left Ventricular Function Assessed by Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2021 05; 14(5):1076-1078.
    View in: PubMed
    Score: 0.038
  36. Subintimal Plaque Modification and Subintimal Dissection and Reentry: Strategies to Turn Failure into Success. Interv Cardiol Clin. 2021 01; 10(1):65-73.
    View in: PubMed
    Score: 0.038
  37. Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction. Cardiovasc Interv Ther. 2021 Oct; 36(4):481-489.
    View in: PubMed
    Score: 0.038
  38. Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 09 28; 13(18):2149-2155.
    View in: PubMed
    Score: 0.038
  39. Use of Intravascular Imaging in Patients With ST-Segment Elevation Acute Myocardial Infarction. Cardiovasc Revasc Med. 2021 09; 30:59-64.
    View in: PubMed
    Score: 0.038
  40. Risk Factors for the Development of Carotid Artery In-Stent Restenosis: Multivariable Analysis. Cardiovasc Revasc Med. 2021 03; 24:65-69.
    View in: PubMed
    Score: 0.038
  41. Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 02; 23:28-35.
    View in: PubMed
    Score: 0.038
  42. Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19. Scott Med J. 2020 Nov; 65(4):123-126.
    View in: PubMed
    Score: 0.038
  43. Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis. Cardiovasc Revasc Med. 2021 01; 22:29-33.
    View in: PubMed
    Score: 0.037
  44. Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2020 05; 13(5):e008900.
    View in: PubMed
    Score: 0.037
  45. Outcomes of Chronic Total?Occlusion Percutaneous Coronary Intervention in Patients With Prior Bypass Surgery. JACC Cardiovasc Interv. 2020 04 13; 13(7):900-902.
    View in: PubMed
    Score: 0.036
  46. Short- and Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2020 10; 21(10):1299-1304.
    View in: PubMed
    Score: 0.036
  47. Primary Orbital Atherectomy for Treating a Heavily Calcified Balloon-Uncrossable Lesion. Cardiovasc Revasc Med. 2020 11; 21(11S):96-99.
    View in: PubMed
    Score: 0.036
  48. Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis. Catheter Cardiovasc Interv. 2021 01 01; 97(1):32-38.
    View in: PubMed
    Score: 0.036
  49. Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement. Am Heart J. 2019 12; 218:128-132.
    View in: PubMed
    Score: 0.036
  50. Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020 11; 96(5):1037-1043.
    View in: PubMed
    Score: 0.036
  51. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values. Circ Cardiovasc Interv. 2019 12; 12(12):e008315.
    View in: PubMed
    Score: 0.036
  52. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management. J Invasive Cardiol. 2019 Jul; 31(7):E177-E183.
    View in: PubMed
    Score: 0.035
  53. Radial Versus Femoral Access in Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 06; 12(6):e007778.
    View in: PubMed
    Score: 0.035
  54. Outcomes with cilostazol after endovascular therapy of peripheral artery disease. Vasc Med. 2019 08; 24(4):313-323.
    View in: PubMed
    Score: 0.034
  55. Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Cardiovasc Revasc Med. 2020 01; 21(1):78-85.
    View in: PubMed
    Score: 0.034
  56. Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv. 2019 04 01; 93(5):E277-E286.
    View in: PubMed
    Score: 0.033
  57. Outcomes With Drug-Coated Balloons for Treating the Side Branch of Coronary Bifurcation Lesions. J Invasive Cardiol. 2018 11; 30(11):393-399.
    View in: PubMed
    Score: 0.033
  58. Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol. 2018 Oct; 31(5):562-571.
    View in: PubMed
    Score: 0.032
  59. Aminophylline for Preventing Bradyarrhythmias During Orbital or Rotational Atherectomy of the Right Coronary Artery. J Invasive Cardiol. 2018 May; 30(5):186-189.
    View in: PubMed
    Score: 0.032
  60. Endovascular Repair of a Large Common Femoral Artery Pseudoaneurysm via a Retrograde Deep Femoral Arterial Access. Cardiovasc Intervent Radiol. 2016 Dec; 39(12):1792-1794.
    View in: PubMed
    Score: 0.028
  61. Etravirine as a culprit of recurrent drug-eluting in-stent restenosis in an HIV patient. Int J Cardiol. 2016 Sep 15; 219:117-8.
    View in: PubMed
    Score: 0.028
  62. Pyogenic granuloma-like Kaposi's sarcoma. Lancet. 2022 04 23; 399(10335):e38.
    View in: PubMed
    Score: 0.027
  63. Effects of supersaturated oxygen therapy on infarct size and microvascular obstruction following myocardial infarction: A systematic review and meta-analysis. Am Heart J. 2026 Mar; 293:107311.
    View in: PubMed
    Score: 0.014
  64. Outcomes of Intracoronary Brachytherapy for In-Stent Restenosis. Am J Cardiol. 2025 Jun 01; 244:89-98.
    View in: PubMed
    Score: 0.013
  65. Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement. Am Heart J. 2025 Feb; 280:79-88.
    View in: PubMed
    Score: 0.013
  66. Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella. J Card Fail. 2024 Oct; 30(10):1287-1299.
    View in: PubMed
    Score: 0.013
  67. Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization-therapy nonresponders. Catheter Cardiovasc Interv. 2024 Oct; 104(4):829-836.
    View in: PubMed
    Score: 0.012
  68. Radiation exposure during distal and traditional radial coronary angiography and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. J Invasive Cardiol. 2023 Nov; 35(11).
    View in: PubMed
    Score: 0.012
  69. Outcomes With Malignancy-Associated High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2024 Jan; 99(1):81-89.
    View in: PubMed
    Score: 0.012
  70. Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Previous Coronary Artery Bypass Graft Surgery. Am J Cardiol. 2023 10 15; 205:40-49.
    View in: PubMed
    Score: 0.012
  71. Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI. JACC Cardiovasc Interv. 2023 06 26; 16(12):1517-1528.
    View in: PubMed
    Score: 0.011
  72. Extra-plaque rotational atherectomy for treating a balloon uncrossable ostial right coronary artery chronic total occlusion. Cardiovasc Revasc Med. 2024 Jan; 58:50-51.
    View in: PubMed
    Score: 0.011
  73. The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study. Catheter Cardiovasc Interv. 2023 07; 102(1):159-165.
    View in: PubMed
    Score: 0.011
  74. Outcomes with catheter-directed thrombolysis vs. catheter-directed embolectomy among patients with high-risk pulmonary embolism: a nationwide analysis. Eur Heart J Acute Cardiovasc Care. 2023 Apr 17; 12(4):224-231.
    View in: PubMed
    Score: 0.011
  75. Intravascular Imaging Use in Percutaneous Coronary Interventions of Chronic Total Occlusions. J Invasive Cardiol. 2023 05; 35(5):E265-E268.
    View in: PubMed
    Score: 0.011
  76. Meta-Analysis on Transcarotid Versus Transfemoral and Other Alternate Accesses for Transcatheter Aortic Valve Implantation. Am J Cardiol. 2023 04 01; 192:196-205.
    View in: PubMed
    Score: 0.011
  77. Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2023 03; 101(4):817-827.
    View in: PubMed
    Score: 0.011
  78. Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry. Catheter Cardiovasc Interv. 2023 03; 101(4):737-746.
    View in: PubMed
    Score: 0.011
  79. External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries. Int J Cardiol. 2023 03 15; 375:14-20.
    View in: PubMed
    Score: 0.011
  80. Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 02 15; 189:76-85.
    View in: PubMed
    Score: 0.011
  81. Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 12; 34(12):E836-E840.
    View in: PubMed
    Score: 0.011
  82. Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2022 11; 100(6):1010-1018.
    View in: PubMed
    Score: 0.011
  83. A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 11; 34(11):E763-E775.
    View in: PubMed
    Score: 0.011
  84. Sex Differences in Management and Outcomes Among Patients With High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2022 10; 97(10):1872-1882.
    View in: PubMed
    Score: 0.011
  85. Hospital procedural volume and outcomes with catheter-directed intervention for pulmonary embolism: a nationwide analysis. Eur Heart J Acute Cardiovasc Care. 2022 Sep 29; 11(9):684-692.
    View in: PubMed
    Score: 0.011
  86. Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2022 10; 100(4):512-519.
    View in: PubMed
    Score: 0.011
  87. Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States. Am J Cardiol. 2022 08 01; 176:132-138.
    View in: PubMed
    Score: 0.011
  88. Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials. Int J Cardiol. 2022 07 15; 359:46-53.
    View in: PubMed
    Score: 0.011
  89. Transcatheter edge-to-edge repair of the tricuspid valve: The US?experience. Catheter Cardiovasc Interv. 2022 05; 99(6):1859-1866.
    View in: PubMed
    Score: 0.011
  90. Temporal Trends in Retrograde Crossing of Epicardial Collaterals in Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 04; 34(4):E294-E295.
    View in: PubMed
    Score: 0.010
  91. Estimate and Temporal Trends of Buerger Disease Hospitalizations in the United States. Am J Cardiol. 2022 04 15; 169:158-160.
    View in: PubMed
    Score: 0.010
  92. In-hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure. Catheter Cardiovasc Interv. 2022 04; 99(5):1572-1581.
    View in: PubMed
    Score: 0.010
  93. Update on chronic total occlusion percutaneous coronary intervention. Prog Cardiovasc Dis. 2021 Nov-Dec; 69:27-34.
    View in: PubMed
    Score: 0.010
  94. Complications of Penumbra Indigo Aspiration Device in Pulmonary Embolism: Insights From MAUDE Database. Cardiovasc Revasc Med. 2022 06; 39:97-100.
    View in: PubMed
    Score: 0.010
  95. Sex Differences in Trends and In-Hospital Outcomes Among Patients With Critical Limb Ischemia: A Nationwide Analysis. J Am Heart Assoc. 2021 09 21; 10(18):e022043.
    View in: PubMed
    Score: 0.010
  96. Impact of Hospital Procedural Volume on?Outcomes After Endovascular Revascularization for Critical Limb?Ischemia. JACC Cardiovasc Interv. 2021 09 13; 14(17):1926-1936.
    View in: PubMed
    Score: 0.010
  97. Computed tomography angiography co-registration with real-time fluoroscopy in percutaneous coronary intervention for chronic total occlusions. EuroIntervention. 2021 Aug 06; 17(5):e433-e435.
    View in: PubMed
    Score: 0.010
  98. Complications and Failure Modes of the Penumbra Indigo CAT RX Aspiration System in Percutaneous Coronary Intervention: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 04; 37:147-148.
    View in: PubMed
    Score: 0.010
  99. Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review. J Thromb Thrombolysis. 2022 Jan; 53(1):51-57.
    View in: PubMed
    Score: 0.010
  100. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
    View in: PubMed
    Score: 0.010
  101. The transseptal puncture experience: Safety insights from FDA MAUDE database. Catheter Cardiovasc Interv. 2021 11 15; 98(6):E855-E861.
    View in: PubMed
    Score: 0.010
  102. Meta-Analysis Comparing Direct Oral Anticoagulants to Vitamin K Antagonists for The Management of Left Ventricular Thrombus. Expert Rev Cardiovasc Ther. 2021 May; 19(5):427-432.
    View in: PubMed
    Score: 0.010
  103. Coronary artery bypass grafting after acute ST-elevation myocardial infarction. J Thorac Cardiovasc Surg. 2023 02; 165(2):672-683.e10.
    View in: PubMed
    Score: 0.010
  104. Benefit of Transcatheter Aortic Valve Replacement in Patients With Paradoxical Low-Flow Low-Gradient Versus High-Gradient Aortic Stenosis and Preserved Left Ventricular Function. Circ Cardiovasc Interv. 2021 03; 14(3):e010042.
    View in: PubMed
    Score: 0.010
  105. Transcatheter Edge to Edge Repair With MitraClip Among Renal Transplant Recipients. Am J Cardiol. 2021 06 01; 148:178-180.
    View in: PubMed
    Score: 0.010
  106. Contemporary Revascularization Strategies and Outcomes Among Patients With Diabetes With Critical Limb Ischemia: Insights From the National Inpatient Sample. JACC Cardiovasc Interv. 2021 03 22; 14(6):664-674.
    View in: PubMed
    Score: 0.010
  107. DOACs for AF After?TAVR: Are DOACs Really on First Base? JACC Cardiovasc Interv. 2021 02 22; 14(4):481.
    View in: PubMed
    Score: 0.010
  108. Hospital Volume and Outcomes of Coronary Atherectomy. Am J Cardiol. 2021 05 01; 146:140-141.
    View in: PubMed
    Score: 0.010
  109. Outcomes of Transcarotid Versus Trans-Subclavian Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 12; 33:20-25.
    View in: PubMed
    Score: 0.010
  110. Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients. Catheter Cardiovasc Interv. 2021 03; 97(4):691-698.
    View in: PubMed
    Score: 0.010
  111. Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed). 2021 Dec; 74(12):1023-1031.
    View in: PubMed
    Score: 0.010
  112. Transulnar Versus Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2021 05; 26:39-45.
    View in: PubMed
    Score: 0.010
  113. Trends and Outcomes of Transcatheter Aortic Valve Implantation Among Solid Organ Transplant Recipients. Am J Cardiol. 2021 01 01; 138:122-124.
    View in: PubMed
    Score: 0.009
  114. Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease. Vasc Med. 2021 04; 26(2):155-163.
    View in: PubMed
    Score: 0.009
  115. Outcomes with catheter-directed thrombolysis compared with anticoagulation alone in patients with acute deep venous thrombosis. Catheter Cardiovasc Interv. 2021 01 01; 97(1):E61-E70.
    View in: PubMed
    Score: 0.009
  116. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2021 08 01; 98(2):217-222.
    View in: PubMed
    Score: 0.009
  117. Impact of Intravascular Ultrasound Utilization for Stent Optimization on 1-Year Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2020 Oct 01; 32(10):392-399.
    View in: PubMed
    Score: 0.009
  118. Outcomes of Reoperative Coronary Artery Bypass Graft Surgery in the United States. J Am Heart Assoc. 2020 08 04; 9(15):e016282.
    View in: PubMed
    Score: 0.009
  119. Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes. J Invasive Cardiol. 2020 Nov; 32(11):433-439.
    View in: PubMed
    Score: 0.009
  120. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review. Am J Med. 2020 11; 133(11):1266-1273.e6.
    View in: PubMed
    Score: 0.009
  121. Clinical Characteristics and Outcomes?of?STEMI Patients With Cardiogenic Shock and Cardiac Arrest. JACC Cardiovasc Interv. 2020 05 25; 13(10):1211-1219.
    View in: PubMed
    Score: 0.009
  122. Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction. Am J Med. 2020 11; 133(11):1293-1301.e1.
    View in: PubMed
    Score: 0.009
  123. The Impact of Novel X-Ray Systems and X-Ray System Optimization on Patient Radiation Dose Administered During Cardiac Catheterization. J Invasive Cardiol. 2020 06; 32(6):218-221.
    View in: PubMed
    Score: 0.009
  124. Racial Disparities in the Utilization and Outcomes of Transcatheter Mitral Valve Repair: Insights From a National Database. Cardiovasc Revasc Med. 2020 11; 21(11):1425-1430.
    View in: PubMed
    Score: 0.009
  125. Use of Radiation Protection Measures in Live Percutaneous Coronary Interventions Cases at Interventional Scientific Meetings. JACC Cardiovasc Interv. 2020 04 13; 13(7):905-906.
    View in: PubMed
    Score: 0.009
  126. Distal Versus Conventional Transradial Artery Access for Coronary Angiography and Intervention: A Meta-Analysis. Cardiovasc Revasc Med. 2020 10; 21(10):1209-1213.
    View in: PubMed
    Score: 0.009
  127. Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via?Saphenous Vein Graft. JACC Cardiovasc Interv. 2020 02 24; 13(4):517-526.
    View in: PubMed
    Score: 0.009
  128. Sex Differences in In-Hospital Outcomes of Transcatheter Mitral Valve Repair (from a National Database). Am J Cardiol. 2020 05 01; 125(9):1391-1397.
    View in: PubMed
    Score: 0.009
  129. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair Among Nonagenarians. JACC Cardiovasc Interv. 2020 06 08; 13(11):1385-1387.
    View in: PubMed
    Score: 0.009
  130. Meta-Analysis Comparing Percutaneous to Surgical Access in Trans-Femoral Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 04 15; 125(8):1239-1248.
    View in: PubMed
    Score: 0.009
  131. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
    View in: PubMed
    Score: 0.009
  132. Spontaneous coronary artery dissection: Primum non nocere. Hellenic J Cardiol. 2020 May - Jun; 61(3):229-230.
    View in: PubMed
    Score: 0.009
  133. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure. Am J Cardiol. 2020 01 01; 125(1):92-99.
    View in: PubMed
    Score: 0.009
  134. Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute?Myocardial Infarction. JACC Cardiovasc Interv. 2019 09 23; 12(18):1825-1836.
    View in: PubMed
    Score: 0.009
  135. In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease. Cardiovasc Revasc Med. 2020 05; 21(5):604-609.
    View in: PubMed
    Score: 0.009
  136. Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 04 01; 95(5):1034-1041.
    View in: PubMed
    Score: 0.009
  137. Low-Risk Transcatheter Versus Surgical Aortic Valve Replacement - An Updated Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2020 04; 21(4):441-452.
    View in: PubMed
    Score: 0.009
  138. Aspirin for Primary Prevention of Cardiovascular?Events. J Am Coll Cardiol. 2019 06 18; 73(23):2915-2929.
    View in: PubMed
    Score: 0.009
  139. Recent advances in microcatheter technology for the treatment of chronic total occlusions. Expert Rev Med Devices. 2019 Apr; 16(4):267-273.
    View in: PubMed
    Score: 0.009
  140. In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians. Catheter Cardiovasc Interv. 2019 04 01; 93(5):989-995.
    View in: PubMed
    Score: 0.008
  141. Outcomes of Surgical Ablation in Patients With Atrial Fibrillation Undergoing Cardiac Surgeries. Ann Thorac Surg. 2019 May; 107(5):1395-1400.
    View in: PubMed
    Score: 0.008
  142. Flow convergence visualized in mitral regurgitation with spontaneous echo contrast. Int J Cardiovasc Imaging. 2019 Mar; 35(3):439-440.
    View in: PubMed
    Score: 0.008
  143. Reply. Ann Thorac Surg. 2018 11; 106(5):1590-1591.
    View in: PubMed
    Score: 0.008
  144. Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery. Ann Thorac Surg. 2018 05; 105(5):1403-1410.
    View in: PubMed
    Score: 0.008
  145. Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Am J Cardiol. 2017 Oct 01; 120(7):1055-1061.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.